COVAX-19 vaccine to enter human trials

Photo: SA virus vaccine to enter human trials
A vaccine candidate for COVID-19 is about to enter human trials in Adelaide, with 40 volunteers aged between 18 and 65 to be given two doses three weeks apart.
The first potential coronavirus vaccine developed in the southern hemisphere is set to begin human trials in Adelaide, with volunteers praised for their efforts to help save the world from the killer disease.
Australian company Vaxine will use a clinical trial unit at the Royal Adelaide Hospital to test the COVAX-19 vaccine.
Forty volunteers aged between 18 and 65 will be given two doses three weeks apart and will then have blood tests to measure protective antibody and their responses.
Vaxine research director Nikolai Petrovsky says COVAX-19 uses a type of technology that mirrors previous work on vaccines for the SARS coronavirus.
The first potential coronavirus vaccine developed in the southern hemisphere is set to begin human trials in Adelaide, with volunteers praised for their efforts to help save the world from the killer disease.
Australian company Vaxine will use a clinical trial unit at the Royal Adelaide Hospital to test the COVAX-19 vaccine.
Forty volunteers aged between 18 and 65 will be given two doses three weeks apart and will then have blood tests to measure protective antibody and their responses.
Vaxine research director Nikolai Petrovsky says COVAX-19 uses a type of technology that mirrors previous work on vaccines for the SARS coronavirus.
He says that is believed to provide the most certain and reliable results.
Known as the recombinant spike protein approach, it seeks to induce a hormonal and cellular immune response.
"As early as January 2020, our modelling identified that COVID-19 as a major pandemic threat that could potentially cause millions of deaths globally," Professor Petrovsky said.
"Unfortunately, our early predictions were spot on."
Vaxine business manager Sarah Pringle said the company had been working for 18 years to develop a successful pandemic vaccine platform.
"Pandemic research is not something you can turn on and off like a tap," she said.
"People should not think that short-term funds, no matter how large, can deliver instant pandemic solutions after a crisis hits; it will always be too little, too late."
South Australian Health Minister Stephen Wade said the willingness of volunteers to take part in the trial could play a key role in conquering COVID-19.
"As we can see with this trial today, by having local health networks that are friendly to research, we can actually give South Australians access to the very latest cutting edge technology and care," he said.
"We've got a strong emphasis on building medical research and programs such as this.
"We're very keen to make sure our facilities are not only delivering high-quality care for South Australians but also are the base for economic development."
Known as the recombinant spike protein approach, it seeks to induce a hormonal and cellular immune response.
"As early as January 2020, our modelling identified that COVID-19 as a major pandemic threat that could potentially cause millions of deaths globally," Professor Petrovsky said.
"Unfortunately, our early predictions were spot on."
Vaxine business manager Sarah Pringle said the company had been working for 18 years to develop a successful pandemic vaccine platform.
"Pandemic research is not something you can turn on and off like a tap," she said.
"People should not think that short-term funds, no matter how large, can deliver instant pandemic solutions after a crisis hits; it will always be too little, too late."
South Australian Health Minister Stephen Wade said the willingness of volunteers to take part in the trial could play a key role in conquering COVID-19.
"As we can see with this trial today, by having local health networks that are friendly to research, we can actually give South Australians access to the very latest cutting edge technology and care," he said.
"We've got a strong emphasis on building medical research and programs such as this.
"We're very keen to make sure our facilities are not only delivering high-quality care for South Australians but also are the base for economic development."
Related Articles
Comments
Featured jobs
Behaviour Support Practitioner
AnglicareSA - Adelaide 21-01-2021
Provide life changing Behaviour Support to adults, young people and children living with a disabilit
Registered Nurse- UK - All Disciplines
Clinical Nursing Fellowship Programme - 18-01-2021
Travel, Learn and Earn! Are you looking to work abroad and do something different? Come and Join

Related jobs
Casual Research Officer
GenesisCare - 22-01-2021
We are seeking a pro-active, efficient and professional individual to join our national research and developme
Locum Occupational Therapist
Careers Connections International - 22-01-2021
ASAP start for 6 weeks + possible extension HP4 level role Transition Care Program, Community Rehabilitation